11. August 2026

ÜBER DIESE EPISODE

In this episode of The Connect Current, we sit down with Ramesh Ramji, Founder and CEO of SpectralTx, to explore how spectral hyperplexing technology could help reshape molecular screening and the future of connected data. Ramesh shares how SpectralTx is developing tools like Spectra-Gel and SpELs to improve encoding depth, speed and data fidelity, giving researchers richer information for drug discovery, diagnostics, deep learning and broader biotech innovation. The conversation dives into why better molecular screening matters, what it takes to build a deep tech life sciences platform, and how SpectralTx’s journey as a Connect Springboard Company reflects San Diego’s strength in turning complex science into real-world opportunity.

Recorded at BioLabs San Diego:
https://www.biolabs.io/san-diego/

Learn more about SpectralTx:
https://spectraltx.com/

Wirtschaft

Wissenschaft

Technologie

Englisch

Vereinigte Staaten

Verwenden SieAPI, um diese Episode inJSONabzurufen

IN DIESER FOLGE

ramesh ramji

Diese Tags bearbeiten

TRANSKRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von The Connect Current durchsuchen.

Betten Sie diese Suchleiste in Ihre Website ein

WEITERE EPISODEN IN DIESEM PODCAST

Targeted Cancer Therapies and the Fight to Make Treatment Less Fearful featuring Stanley Lewis

28. Juli 2026

In this episode of The Connect Current, we sit down with Stanley Lewis, MD, MPH, Founder and CEO of A28 Therapeutics, to explore how targeted cancer therapies can create better options for patients facing difficult diseases. Stanley shares the story behind A28’s targeted oncolytic peptide platform,…

00:21:58

SPEICHERN

Clip

Solving the Delivery Challenge in Genetic Medicine featuring Niren Shah

4. August 2026

In this episode of The Connect Current, we sit down with Niren Shah, PharmD, MBA, Co-founder and CEO of Cove Therapeutics, to explore one of the biggest challenges in genetic medicine: delivery. Niren shares how Cove is developing non-lipid, non-viral biodegradable polymeric nanoparticles designed …

00:20:01

SPEICHERN

Clip

Advancing a New Treatment Path for Gout featuring James Mackay

18. August 2026

In this episode of The Connect Current, we sit down with James Mackay, Ph.D., President and CEO of Crystalys Therapeutics, to explore how the company is advancing a new treatment path for people living with gout. James shares how Crystalys is developing dotinurad, a next-generation, once-daily oral…

00:19:01

SPEICHERN

Clip

Turning the Ocean Into a Sensing Network featuring Graeme Rae

25. August 2026

In this episode of The Connect Current, we sit down with Graeme Rae, Ph.D., Founder and CEO of HyperKelp, to explore how the company is turning the ocean into a sensing network. Graeme shares how HyperKelp’s Kelp Smart Buoy is designed as an open marine platform that can carry a wide range of senso…

00:24:24

SPEICHERN

Clip

Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Connect, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.